[1] |
Nieuwkamp DJ, Setz LE, Algra A, et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time,according to age, sex, and region: a meta-analysis[J]. Lancet Neurol, 2009, 8(7): 635-642.
|
[2] |
Etminan N, Rinkel G J. Unruptured intracranial aneurysms: development, rupture and preventive management[J]. Nat Rev Neurol, 2017, 13(2): 126.
|
[3] |
中国医师协会神经介入专业委员会, 中国颅内动脉瘤计划研究组. 中国颅内未破裂动脉瘤诊疗指南2021[J]. 中国脑血管病杂志, 2021, 18(9): 634-664.
|
[4] |
Molyneux AJ, Birks J, Clarke A, et al. The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the international subarachnoid aneurysm trial[J]. Lancet, 2015, 385(9969): 691-697.
|
[5] |
Wiebers DO, Whisnant JP, Huston JR, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment[J]. Lancet, 2003, 362(9378): 103-110.
|
[6] |
Byrne JV, Beltechi R, Yarnold JA, et al. Early experience in the treatment of intra-cranial aneurysms by endovascular flow diversion: a multicentre prospective study[J]. PLoS One, 2010, 5(9): e12492.
|
[7] |
Setlur NS, Vakharia K, Waqas M, et al. Single-center experience of using high definition (Hi-Def) imaging during neurointervention treatment of intracranial aneurysms using flow diverters[J]. J Neurointerv Surg, 2020, 12(9): 897-901.
|
[8] |
Fiorella D, Lylyk P, Szikora I, et al. Curative cerebrovascular reconstruction with the pipeline embolization device: the emergence of definitive endovascular therapy for intracranial aneurysms[J]. J Neurointerv Surg, 2018, 10(Suppl 1): i9-i18.
|
[9] |
Kallmes DF, Brinjikji W, Cekirge S, et al. Safety and efficacy of the pipeline embolization device for treatment of intracranial aneurysms: a pooled analysis of 3 large studies[J]. J Neurosurg, 2017, 127(4): 775-780.
|
[10] |
Kang H, Zhou Y, Luo B, et al. Pipeline embolization device for intracranial aneurysms in a Large Chinese cohort: complication risk factor analysis[J]. Neurotherapeutics, 2021, 18(2): 1198-1206.
|
[11] |
Luo B, Kang H, Zhang H, et al. Pipeline embolization device for intracranial aneurysms in a large Chinese cohort: factors related to aneurysm occlusion[J]. Ther Adv Neurol Disord, 2020, 13: 1279189396.
|
[12] |
Hanel RA, Kallmes DF, Lopes DK, et al. Prospective study on embolization of intracranial aneurysms with the pipeline device: the premier study 1 year results[J]. J Neurointerv Surg, 2020, 12(1): 62-66.
|
[13] |
Pierot L, Spelle L, Berge J, et al. SAFE study (safety and efficacy Analysis of fred embolic device in aneurysm treatment): 1-year clinical and anatomical results[J]. J Neurointerv Surg, 2019, 11(2): 184-189.
|
[14] |
Dmytriw AA, Phan K, Moore JM, et al. On flow diversion: the changing landscape of intracerebral aneurysm management[J]. AJNR Am J Neuroradiol, 2019, 40(4): 591-600.
|
[15] |
Aquarius R, de Korte A, Smits D, et al. The importance of wall apposition in flow diverters[J]. Neurosurgery, 2019, 84(3):804-810.
|
[16] |
Liang F, Zhang Y, Yan P, et al. Outcomes and complications after the Use of the pipeline embolization device in the treatment of intracranial aneurysms of the posterior circulation: a systematic review and meta-analysis[J]. World Neurosurg, 2019, 127: e888-e895.
|
[17] |
Orth RC, Wallace MJ, Kuo MD. C-arm cone-beam CT: general principles and technical considerations for use in interventional radiology[J]. J Vasc Interv Radiol, 2009, 20(7 Suppl): S538-S544.
|
[18] |
吉喆, 耿介文, 翟晓东, 等. 颅内动脉瘤影像学判读专家共识[J]. 中国脑血管病杂志, 2021, 18(7): 492-504.
|